AFP and neoplasm: The VICT2 trait was associated with serum AFP > 400 ng/mL (33% vs. 23% p = 0.03), more frequent poor tumor differentiation (41% vs. 28%, p = 0.004), MVI (58% vs. 8%, p < 0.001), and MTM subtype (32% vs. 13%, p = 0.003).